Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00706394 · ClinicalTrials.gov registry record · NA
34mm Cuff Study for Endovascular Repair of Abdominal Aortic Aneurysms
A NA study, sponsored by Endologix.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT00706394: Completed NA study, sponsored by Endologix.
NCT00706394 is a NA study that has completed, run by Endologix. The registered enrollment target is 19 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00706394, a NA study, has completed, sponsored by Endologix.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
Study of anatomical fixation with a 34mm proximal extension
Primary Outcome
Percentage of patients with Type Ia endoleaks at each timepoint (discharge, 1, 6, 12, 24, 36, 48 and 60 months).
Interventions
- DEVICE Endologix Powerlink 34 mm stent graft cuff
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2007-08-10 |
| Est. Completion | 2013-09 |
| Phase | NA |
What the finished NCT00706394 record still lists
NCT00706394 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Endologix Powerlink 34 mm stent graft cuff is the first listed.
NCT00706394 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00706394 about?
NCT00706394 is a clinical study titled "34mm Cuff Study for Endovascular Repair of Abdominal Aortic Aneurysms". Study of anatomical fixation with a 34mm proximal extension
What is the current status of trial NCT00706394?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2007-08-10. Estimated completion is 2013-09.
What interventions are being tested in trial NCT00706394?
The interventions under investigation include: Endologix Powerlink 34 mm stent graft cuff (DEVICE).
Who is sponsoring clinical trial NCT00706394?
This trial is sponsored by Endologix, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00706394's enrollment target sits among peer trials
19 1861st of 2000 higher than 138 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI